pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,879 catalysts · 4,876 phase readout · 2,350 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 12 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,350
  • earnings286
  • pdufa275
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Infectious Disease3

    Date TBD

    50
    ›RECRUITINGphase readoutNCT06028828: Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation

    Sponsor: University of California, Irvine. Phase: PHASE2. Conditions: Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03178617: High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma

    Sponsor: City of Hope Medical Center. Phase: NA. Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Lymphoblastic Lymphoma, Acute Leukemia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07351240: The Acupuncture Treatment Effect in Patients With Schizophrenia

    Sponsor: Calo Psychiatric Center. Phase: NA. Conditions: Mental Health

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05968989: Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE1. Conditions: Influenza

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05658068: Systems Aligning for Equity (SAFE) Spaces

    Sponsor: New York University. Phase: NA. Conditions: Suicide, Mental Disorder, Mental Health, Burnout, Professional, Self Harm

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07401550: Assessment and Prediction of Cardiovascular Health and Disease Risk Using Wearable Biometrics.

    Sponsor: University College Dublin. Phase: . Conditions: Cardiovascular Diseases (CVD), Cardiovascular Disease Prevention, Cardiovascular Disease Risk Factor, Coronary Artery Disease (CAD)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07415291: CNN-Based AI Versus Physicians for Solitary Skin Lesion Diagnosis

    Sponsor: Istanbul Training and Research Hospital. Phase: . Conditions: Solitary Skin Lesions, Skin Neoplasms, Skin Neoplasm Malignant

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06788691: Luspatercept for Clonal Cytopenias of Uncertain Significance

    Sponsor: Weill Medical College of Cornell University. Phase: PHASE2. Conditions: CCUS Clonal Cytopenia of Undetermined Significance, Anemia, Leukopenia, Thrombocytopenia, Neutropenia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07201974: Virtual Reality for Post-Stroke Gait Rehabilitation

    Sponsor: McGill University. Phase: NA. Conditions: Stroke

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03360890: Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors

    Sponsor: University of Chicago. Phase: PHASE2. Conditions: Thyroid Cancer, Salivary Gland Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07425197: Comparative Effects of Two Rehabilitation Approaches on Lumbopelvic Function in Sacroiliac Joint Dysfunction

    Sponsor: Lahore University of Biological and Applied Sciences. Phase: NA. Conditions: Sacroiliac Joint Dysfunction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT01893710: International (Pediatric) Peritoneal Biobank

    Sponsor: Heidelberg University. Phase: . Conditions: Kidney Failure, Chronic, Peritoneal Dialysis Complication, Transplantation, Healthy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05224713: Correlations Between Press Ganey Hospital and Ambulatory Scores for a Neurosurgical Practice

    Sponsor: Methodist Health System. Phase: . Conditions: Satisfaction, Patient

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07451613: Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease

    Sponsor: Leslie Thompson. Phase: PHASE1. Conditions: Huntington Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03782610: Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes

    Sponsor: Nationwide Children's Hospital. Phase: . Conditions: Patent Ductus Arteriosus, Preterm Infant, Bronchopulmonary Dysplasia, Neurodevelopmental Abnormality

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07328282: Comparative Effects Between ELDOA and Spinal Mobilization With Limb Movement in Lumbar Radiculopathy

    Sponsor: Foundation University Islamabad. Phase: NA. Conditions: Lumbar Radiculopathy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07454096: Application of Radiomics for Diagnosis and Follow-up of Cardiovascular Device Infections: PREDICT Study

    Sponsor: Fundacion Clinic per a la Recerca Biomédica. Phase: PHASE4. Conditions: Cardiac Disease, Device Related Infection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07275762: Y-4 to Treat the Postherpetic Neuralgia

    Sponsor: Neurodawn Pharmaceutical Co., Ltd.. Phase: PHASE2. Conditions: Postherpetic Neuralgia, Y-4, Pregabalin

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07422662: Arthroscopic Treatment of Acetabular Labral Lesions: Intrarticular Injection of Bone Marrow vs Hip Arthroscopy Alone

    Sponsor: Istituto Ortopedico Rizzoli. Phase: NA. Conditions: FemoroAcetabular Impingement

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04690946: Comparing Effect and Change Processes in Cognitive Behavioral Therapy and Emotion-Focused Therapy for Depression

    Sponsor: Institutt for Psykologisk Radgivning. Phase: NA. Conditions: Depression

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07196046: Product Responsiveness to Enhanced Bioavailability Curcumin Dietary Supplements in Adults

    Sponsor: Ultra Botanica LLC. Phase: NA. Conditions: Joint Discomfort, Quality of Life (QOL)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07041203: Extended-release Sodium Oxybate (Lumryz) in Spasmodic Dysphonia and Voice Tremor

    Sponsor: Kristina Simonyan. Phase: PHASE1. Conditions: Spasmodic Dysphonia, Laryngeal Dystonia, Voice Tremor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04606446: Study of PF-07248144 in Advanced or Metastatic Solid Tumors

    Sponsor: Pfizer. Phase: PHASE2. Conditions: Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07274527: Amnioinfusion's Protective Effects on Respiratory and Longitudinal Pediatric Outcomes After Intrapartum Thick Meconium Exposure

    Sponsor: Medical College of Wisconsin. Phase: NA. Conditions: Neonatal Respiratory Distress Related Conditions, Meconium, Perinatal Morbidity, Neonatal Acidosis, Cord Blood, Neonatal Brain Injury, Maternal Morbidity, Mechanical Ventilation, CPAP, Surfactant, Perinatal Death, Amnioinfusion, NICU Admission

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07496827: Detection of Parasitic Infections in Patients With Haematological Disorders in Assiut University Hospitals

    Sponsor: Assiut University. Phase: . Conditions: Haematological Disorders

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06047327: EUS-guided Versus Percutaneous Ultrasound-guided Biopsy for Parenchymal Liver Disease

    Sponsor: Institute of Liver and Biliary Sciences, India. Phase: NA. Conditions: Liver Cirrhosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06988488: A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma

    Sponsor: Celgene. Phase: PHASE1. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06895070: XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

    Sponsor: XVIVO Perfusion. Phase: NA. Conditions: Heart Transplant, Heart Failure, Transplant; Failure, Heart

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT05893069: Oxandrolone Multiligament Knee

    Sponsor: George F. Hatch. Phase: PHASE4. Conditions: Ligament Tear Knee

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07177183: Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure

    Sponsor: University Hospital Ostrava. Phase: NA. Conditions: Prolonged Mechanical Ventilation, Critical Illness

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT00060541: Evaluation and Treatment of Neurosurgical Disorders

    Sponsor: National Institute of Neurological Disorders and Stroke (NINDS). Phase: . Conditions: Neurologic Disorders

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07440641: RE-FIT (Remote Exercise for Physical Function in WTC Responders With Prostate Cancer)

    Sponsor: University of Vermont. Phase: NA. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04331041: Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma

    Sponsor: Washington University School of Medicine. Phase: PHASE2. Conditions: Pancreas Cancer, Cancer of the Pancreas, Pancreas Adenocarcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07467694: Postnatal Exercise to Activate Baby's Brown Fat

    Sponsor: Joslin Diabetes Center. Phase: NA. Conditions: Childhood Obesity Prevention, Childhood Obesity, Physical Activity, Lactation, Breastfeeding, Pregnancy, Exercise

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07525466: Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH)

    Sponsor: Beijing Tongren Hospital. Phase: PHASE1. Conditions: Extranodal NK T Cell Lymphoma, Hemophagocytic Lymphohistiocytosis (HLH)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06883266: Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD

    Sponsor: Sanford Health. Phase: NA. Conditions: Parkinsons Disease (PD)

    full page →ctgov ↗
    ›AVAILABLEphase readoutNCT06915766: Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis

    Sponsor: Cogent Biosciences, Inc.. Phase: . Conditions: Systemic Mastocytoses, Indolent, Systemic Mastocytoses, Aggressive

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07429656: Active Apex Correction (APC) for Early Onset Scoliosis. Early Results of a Pilot Study.

    Sponsor: Assiut University. Phase: NA. Conditions: Early Onset Scoliosis (EOS)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04233866: Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread

    Sponsor: ECOG-ACRIN Cancer Research Group. Phase: PHASE2. Conditions: Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07337135: Opioid-Free vs Opioid-Based Anesthesia in Bariatric Surgery

    Sponsor: Hospital dos Lusíadas. Phase: NA. Conditions: Morbid Obesity, Postoperative Pain, Opioid Free Anesthesia, Bariatric Surgery

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07116525: A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter

    Sponsor: Biosense Webster, Inc.. Phase: NA. Conditions: Scar-related Atrial Tachycardia, Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation, Ventricular Procedures, Ventricular Tachycardia, Ischemic Ventricular Tachycardia, Non-ischemic Ventricular Tachycardia, Cardiomyopathy, Idiopathic Ventricular Tachycardia, Premature Ventricular Contraction

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05524025: The SPOT-HPV Study

    Sponsor: Dana-Farber Cancer Institute. Phase: . Conditions: HPV Infection, HPV Positive Oropharyngeal Squamous Cell Carcinoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07433517: VGN-Ex05e in Patients With Autism Spectrum Disorder Associated With Severe Self-Injurious and Aggressive Behaviors

    Sponsor: Shanghai Jiao Tong University School of Medicine. Phase: EARLY_PHASE1. Conditions: Autism Spectrum Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07435168: CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis

    Sponsor: Rigshospitalet, Denmark. Phase: NA. Conditions: Cardiac Amyloidosis, Chest Pain

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02158091: A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL

    Sponsor: Dana-Farber Cancer Institute. Phase: PHASE1. Conditions: Chronic Lymphocytic Leukemia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07374497: Effect of Perineal Massage on the Frequency of Episiotomy and Perineal Tearing

    Sponsor: Sheikh Zayed Medical College. Phase: NA. Conditions: Episiotomy Extended by Laceration

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06757010: A Study of NE3107 in Early Parkinson's

    Sponsor: BioVie Inc.. Phase: PHASE2. Conditions: Parkinsons Disease (PD)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07374913: COL4A1COL4A2: Study of Pathological Conditions Involving Multiple Organs Caused by Mutations in the COL4A1 and COL4A2 Genes

    Sponsor: Meyer Children's Hospital IRCCS. Phase: NA. Conditions: COL4A1\2, COL4A1-Related Brain Small Vessel Disease With Haemorrhage

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06351020: LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma.

    Sponsor: LaNova Medicines Zhejiang Co., Ltd.. Phase: PHASE3. Conditions: Locally Advanced or Metastatic GC and GCJ Adenocarcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04398082: TRANslating Sleep Health Into QUaLity of Recovery (TRANQUiL) Study

    Sponsor: Women's College Hospital. Phase: . Conditions: Sleep Disorder, Sleep Disturbance

    full page →ctgov ↗
    ← prev
    page 11 of 98
    next →